Track LBRX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
LBRX - LB Pharmaceuticals Inc Common Stock (LBRX) has a free cash flow of -$51.71M, up 34.5% over the past year.
FCF TTM
-$51.71M
FCF Margin
-
FCF Yield
-5.11%
5Y CAGR
-
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$35.26M | +34.49% |
| 2024 | -$53.82M | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q1 2026 | -$23.32M | -28.55% |
| Q4 2025 | -$18.14M | -437.89% |
| Q3 2025 | -$3.37M | +50.92% |
| Q2 2025 | -$6.87M | +0.00% |
| Q1 2025 | -$6.87M | -16.42% |
| Q4 2024 | -$5.90M | +73.74% |
| Q3 2024 | -$22.48M | -42.12% |
| Q2 2024 | -$15.82M | -64.43% |
| Q1 2024 | -$9.62M | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.